Shares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug.Canopy Growth Corporation saw the biggest increase, with CGC stock closing ...
Source LinkShares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug.Canopy Growth Corporation saw the biggest increase, with CGC stock closing ...
Source Link
Comments